Skip to Main Content

Author Details

Ashley Margol
Children's Hospital Los Angeles
2010
41
14
PMIDPaper TitleJournal TitlePublished Year
36128892MR multitasking-based dynamic imaging for cerebrovascular evaluation (MT-DICE): Simultaneous quantification of permeability and leakage-insensitive perfusion by dynamic T 1 / T 2 * mapping.Magn Reson Med2023
36128892MR multitasking-based dynamic imaging for cerebrovascular evaluation (MT-DICE): Simultaneous quantification of permeability and leakage-insensitive perfusion by dynamic T 1 / T 2 * mapping.Magn Reson Med2023
35604410Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.Neuro Oncol2023
36773516Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor.Neoplasia2023
37461402Low-pass whole-genome and targeted sequencing of cell-free DNA from cerebrospinal fluid in pediatric patients with central nervous system tumors.Neurooncol Adv2023
37204254Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.Oncotarget2023
36548930Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.J Clin Oncol2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
35604410Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.Neuro Oncol2023
37461402Low-pass whole-genome and targeted sequencing of cell-free DNA from cerebrospinal fluid in pediatric patients with central nervous system tumors.Neurooncol Adv2023
37204254Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.Oncotarget2023
36548930Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.J Clin Oncol2023
36773516Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor.Neoplasia2023
36268104Quantitative Nuclear Histomorphometry Predicts Molecular Subtype and Clinical Outcome in Medulloblastomas: Preliminary Findings.J Pathol Inform2022
35397478Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma.Neuro Oncol2022
36072789Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data.Front Oncol2022
35686831Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome.Pediatr Blood Cancer2022
36268104Quantitative Nuclear Histomorphometry Predicts Molecular Subtype and Clinical Outcome in Medulloblastomas: Preliminary Findings.J Pathol Inform2022
36620600Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study.Front Oncol2022
35397478Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma.Neuro Oncol2022
35686831Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome.Pediatr Blood Cancer2022
36620600Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study.Front Oncol2022
36072789Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data.Front Oncol2022
33480656Primary Primitive Neuroectodermal Tumor of the Spine With t(11;22): Report of 3 Cases and Review of Literature.J Pediatr Hematol Oncol2021
34125480Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.Pediatr Blood Cancer2021
33480656Primary Primitive Neuroectodermal Tumor of the Spine With t(11;22): Report of 3 Cases and Review of Literature.J Pediatr Hematol Oncol2021
33960568IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature.Brain Pathol2021
33948563Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults.Neurooncol Adv2021
34125480Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.Pediatr Blood Cancer2021
33960568IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature.Brain Pathol2021
33948563Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults.Neurooncol Adv2021
32129445Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.Neuro Oncol2020
31912158SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.Neuro Oncol2020
32129445Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.Neuro Oncol2020
31951480Primary diffuse leptomeningeal glioneuronal tumors of the central nervous system: Report of three cases and review of literature.Pediatr Hematol Oncol2020
32573959Central diabetes insipidus: A rare unreported side effect of temozolomide in pediatrics.Pediatr Blood Cancer2020
33163308Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series.Cureus2020
31951480Primary diffuse leptomeningeal glioneuronal tumors of the central nervous system: Report of three cases and review of literature.Pediatr Hematol Oncol2020
31912158SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.Neuro Oncol2020
33163308Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series.Cureus2020
32573959Central diabetes insipidus: A rare unreported side effect of temozolomide in pediatrics.Pediatr Blood Cancer2020
30728904Sustained response of three pediatric BRAF<sup>V600E</sup> mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.Oncotarget2019
31621042Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.J Neurooncol2019
31502379Clinical and neuropsychological outcome of pediatric non-midline central nervous system germinoma treated with chemotherapy and reduced dose/volume irradiation: The Children's Hospital Los Angeles experience.Pediatr Blood Cancer2019
30728904Sustained response of three pediatric BRAF<sup>V600E</sup> mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.Oncotarget2019
30948375Pediatric Atypical Teratoid/Rhabdoid Tumors of the Brain: Identification of Metabolic Subgroups Using In Vivo <sup>1</sup>H-MR Spectroscopy.AJNR Am J Neuroradiol2019
31502379Clinical and neuropsychological outcome of pediatric non-midline central nervous system germinoma treated with chemotherapy and reduced dose/volume irradiation: The Children's Hospital Los Angeles experience.Pediatr Blood Cancer2019
31621042Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.J Neurooncol2019
30948375Pediatric Atypical Teratoid/Rhabdoid Tumors of the Brain: Identification of Metabolic Subgroups Using In Vivo <sup>1</sup>H-MR Spectroscopy.AJNR Am J Neuroradiol2019
  • 1 - 50 of 82

Recommended Authors

Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Institute Curie
Career Start Year 2014
Number of shared co-authors 27
Nationwide Children's Hospital and The Ohio State University
Career Start Year 2013
Number of shared co-authors 11
Feinberg School of Medicine, Northwestern University
Career Start Year 2011
Number of shared co-authors 2
Institute for Genomic Medicine, Nationwide Children's Hospital
Career Start Year 2011
Number of shared co-authors 0
Children's National Hospital
Career Start Year 2009
Number of shared co-authors 29
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Career Start Year 2009
Number of shared co-authors 35
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year 2008
Number of shared co-authors 28
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 22
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2008
Number of shared co-authors 37
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2006
Number of shared co-authors 41
Universite Paris-Saclay
Career Start Year 2006
Number of shared co-authors 29
Stanford University
Career Start Year 2006
Number of shared co-authors 38
St. Jude Children's Research Hospital
Career Start Year 2004
Number of shared co-authors 30
MacKay Memorial Hospital
Career Start Year 2003
Number of shared co-authors 8
Necker Hospital, Assistance Publique-Hopitaux de Paris
Career Start Year 2000
Number of shared co-authors 34
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 30
University of Texas Southwestern Medical School
Career Start Year 1998
Number of shared co-authors 36
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 1998
Number of shared co-authors 31
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Career Start Year 1996
Number of shared co-authors 29
University Children's Hospital
Career Start Year 1994
Number of shared co-authors 31
Children's Hospitals and Clinics of Minnesota
Career Start Year 1993
Number of shared co-authors 30
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 32
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 1990
Number of shared co-authors 28
University of Pittsburgh School of Medicine
Career Start Year 1987
Number of shared co-authors 47
St. Jude Children's Research Hospital
Career Start Year 1986
Number of shared co-authors 37
The Hospital for Sick Children, University of Toronto
Career Start Year 1986
Number of shared co-authors 35
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 5
DOPO Clinic and Neuroncology Unit, IRCCS Istituto Giannina Gaslini (IGG)
Career Start Year 1983
Number of shared co-authors 25
Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM, University of Paris
Career Start Year 1963
Number of shared co-authors 37

Collaborators

Co-authored papers 17
Co-authored papers 14
Nationwide Children's Hospital and The Ohio State University
Co-authored papers 9
Children's Hospital Los Angeles
Co-authored papers 9
Co-authored papers 6
Co-authored papers 5
Children's Hospital Los Angeles
Co-authored papers 4
Co-authored papers 4
The Hospital for Sick Children
Co-authored papers 4
Arnold Palmer Hospital for Children
Co-authored papers 3
Children's Hospital of Philadelphia
Co-authored papers 3
Brain Tumor Institute, Children's National Hospital
Co-authored papers 3
Rady Children's Hospital San Diego.
Co-authored papers 3
Washington University
Co-authored papers 3
Co-authored papers 3
Hospital for Sick Children
Co-authored papers 3
Co-authored papers 3
University Children's Hospital Zurich
Co-authored papers 3
St. Jude Children's Research Hospital
Co-authored papers 2
Co-authored papers 2
St Jude Children's Research Hospital
Co-authored papers 2
Children's National Hospital
Co-authored papers 2
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
Boston Children's Hospital and Harvard Medical School
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children
Co-authored papers 2
The Hospital for Sick Children
Co-authored papers 2
Children's Hospital of Philadelphia
Co-authored papers 2